P13 BABRAHAM - Revision history https://lipidomicnet.org/index.php?title=P13_BABRAHAM&action=history Revision history for this page on the wiki en MediaWiki 1.13.0 Fri, 29 Mar 2024 12:44:29 GMT Richard Noragon at 13:14, 8 August 2011 https://lipidomicnet.org/index.php?title=P13_BABRAHAM&diff=11110&oldid=prev <p></p> <table style="background-color: white; color:black;"> <col class='diff-marker' /> <col class='diff-content' /> <col class='diff-marker' /> <col class='diff-content' /> <tr valign='top'> <td colspan='2' style="background-color: white; color:black;">←Older revision</td> <td colspan='2' style="background-color: white; color:black;">Revision as of 13:14, 8 August 2011</td> </tr> <tr><td colspan="2" class="diff-lineno">Line 1:</td> <td colspan="2" class="diff-lineno">Line 1:</td></tr> <tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div>{{Infobox_Institution</div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div>{{Infobox_Institution</div></td></tr> <tr><td class='diff-marker'>-</td><td style="background: #ffa; color:black; font-size: smaller;"><div>|myInstitutionname=The Babraham Institute<del class="diffchange diffchange-inline">, Cambridge - Michael Wakelam</del></div></td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div>|myInstitutionname=<ins class="diffchange diffchange-inline">[http://www.babraham.ac.uk/inositide/wakelam.html </ins>The Babraham Institute<ins class="diffchange diffchange-inline">]</ins></div></td></tr> <tr><td class='diff-marker'>-</td><td style="background: #ffa; color:black; font-size: smaller;"><div>|myLogo=</div></td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div>|myLogo=<ins class="diffchange diffchange-inline">[[Image:P13 Babraham Inst.jpg|Image:P13_Babraham_Inst.jpg]]</ins></div></td></tr> <tr><td class='diff-marker'>-</td><td style="background: #ffa; color:black; font-size: smaller;"><div>|myCountry=United <del class="diffchange diffchange-inline">Kingdoms</del></div></td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div><ins class="diffchange diffchange-inline">|myPrincipal_investigator=[[User:Michael Wakelam|Prof. Dr. Michael Wakelam]]</ins></div></td></tr> <tr><td colspan="2">&nbsp;</td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div><ins class="diffchange diffchange-inline">Email: [mailto:michael.wakelam@bbsrc.ac.uk Michael Wakelam]</ins></div></td></tr> <tr><td colspan="2">&nbsp;</td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div><ins class="diffchange diffchange-inline">Telephone:+44 1223-496202</ins></div></td></tr> <tr><td colspan="2">&nbsp;</td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div>|myCountry=United <ins class="diffchange diffchange-inline">Kingdom</ins></div></td></tr> <tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div>|myBenefitnr=P13</div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div>|myBenefitnr=P13</div></td></tr> <tr><td class='diff-marker'>-</td><td style="background: #ffa; color:black; font-size: smaller;"><div>|myAbout=</div></td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div>|myAbout=<ins class="diffchange diffchange-inline">The Babraham Institute is an independent charitable life sciences Institute, sponsored by the</ins></div></td></tr> <tr><td class='diff-marker'>-</td><td style="background: #ffa; color:black; font-size: smaller;"><div>|myContribution=The Wakelam laboratory brings expertise in the study of signal transduction pathways to LipidomicNet. The lab has developed HPLC-MS methods for the analysis of lipids including the phosphoinositides. The lab has expertise in the generation of genetically modified mouse models and through <del class="diffchange diffchange-inline"> </del>association with Birmingham University access to human samples and</div></td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div><ins class="diffchange diffchange-inline">BBSRC, carrying out world-leading innovative research and advanced training with relevance</ins></div></td></tr> <tr><td colspan="2">&nbsp;</td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div><ins class="diffchange diffchange-inline">to the biomedical, biotechnological, pharmaceutical and healthcare research and user</ins></div></td></tr> <tr><td colspan="2">&nbsp;</td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div><ins class="diffchange diffchange-inline">communities. The research focuses on the mechanisms of cell signalling and gene regulation</ins></div></td></tr> <tr><td colspan="2">&nbsp;</td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div><ins class="diffchange diffchange-inline">which underlie normal cellular processes and functions, and on how their failure or</ins></div></td></tr> <tr><td colspan="2">&nbsp;</td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div><ins class="diffchange diffchange-inline">abnormality may lead to disease. The signalling research has a particular focus upon lipid</ins></div></td></tr> <tr><td colspan="2">&nbsp;</td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div><ins class="diffchange diffchange-inline">signalling with phospholipases and PI-3-kinases being major areas, though MAP kinase</ins></div></td></tr> <tr><td colspan="2">&nbsp;</td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div><ins class="diffchange diffchange-inline">signalling is also a key area. The Institute is core funded by the BBSRC and additionally</ins></div></td></tr> <tr><td colspan="2">&nbsp;</td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div><ins class="diffchange diffchange-inline">researchers are funded by the MRC, British Heart Foundation, Wellcome Trust, Cancer</ins></div></td></tr> <tr><td colspan="2">&nbsp;</td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div><ins class="diffchange diffchange-inline">Research UK, Leukaemia Research fund and the EU, as well as attracting significant</ins></div></td></tr> <tr><td colspan="2">&nbsp;</td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div><ins class="diffchange diffchange-inline">industrial funding. The modern research laboratories are well equiped and house more than</ins></div></td></tr> <tr><td colspan="2">&nbsp;</td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div><ins class="diffchange diffchange-inline">300 scientists. Core facilities include mass spectrometry, protein production equipment,</ins></div></td></tr> <tr><td colspan="2">&nbsp;</td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div><ins class="diffchange diffchange-inline">imaging, FACS, animal houses and gene analysis. The Wakelam laboratory has long and</ins></div></td></tr> <tr><td colspan="2">&nbsp;</td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div><ins class="diffchange diffchange-inline">extensive experience in the analysis of lipids and has established the CR-UK Lipidomic</ins></div></td></tr> <tr><td colspan="2">&nbsp;</td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div><ins class="diffchange diffchange-inline">Oncology Program within the Institute. In WP4 Babraham scientists will collaborate closely</ins></div></td></tr> <tr><td colspan="2">&nbsp;</td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div><ins class="diffchange diffchange-inline">with Professor Mark McCarthy and Dr Frederik Karpe of the University of Oxford Centre for</ins></div></td></tr> <tr><td colspan="2">&nbsp;</td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div><ins class="diffchange diffchange-inline">Diabetes, Endocrinology and Metabolism, and Dr John Mclauchlan, MRC Virology Unit,</ins></div></td></tr> <tr><td colspan="2">&nbsp;</td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div><ins class="diffchange diffchange-inline">Glasgow. Professor Wakelam retains an honorary professorial appointment at the University</ins></div></td></tr> <tr><td colspan="2">&nbsp;</td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div><ins class="diffchange diffchange-inline">of Birmingham where he collaborates extensively with Professor David Adams, of the</ins></div></td></tr> <tr><td colspan="2">&nbsp;</td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div><ins class="diffchange diffchange-inline">University of Birmingham Liver Unit who provides clinical material.</ins></div></td></tr> <tr><td colspan="2">&nbsp;</td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div>|myContribution=The Wakelam laboratory brings expertise in the study of signal transduction</div></td></tr> <tr><td colspan="2">&nbsp;</td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div>pathways to LipidomicNet. The lab has developed HPLC-MS methods for the analysis of lipids</div></td></tr> <tr><td colspan="2">&nbsp;</td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div>including the phosphoinositides. The lab has expertise in the generation of genetically</div></td></tr> <tr><td colspan="2">&nbsp;</td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div>modified mouse models and through association with Birmingham University access to human samples and</div></td></tr> <tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div>DNA array facilities.</div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div>DNA array facilities.</div></td></tr> <tr><td class='diff-marker'>-</td><td style="background: #ffa; color:black; font-size: smaller;"><div>|myTaskforces=[[Task_Force_I|Task Force I]], [[Task_Force_II|Task Force II]], [[Task_Force_VI|Task Force VI]], [[Task_Force_VII|Task Force VII]], and [[Task_Force_IX|Task Force IX]]</div></td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div>|myTaskforces=[[Task_Force_I|Task Force I]], [[Task_Force_II|Task Force II]], [[Task_Force_VI|Task Force VI]],</div></td></tr> <tr><td colspan="2">&nbsp;</td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div>[[Task_Force_VII|Task Force VII]], and [[Task_Force_IX|Task Force IX]]</div></td></tr> <tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div>|myWorkpackages=[[WP4|WP4]]</div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div>|myWorkpackages=[[WP4|WP4]]</div></td></tr> <tr><td class='diff-marker'>-</td><td style="background: #ffa; color:black; font-size: smaller;"><div>}}&lt;br&gt; &lt;br&gt; &nbsp;</div></td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div>}}&lt;br&gt; &lt;br&gt;</div></td></tr> <tr><td colspan="2">&nbsp;</td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div>&#160;</div></td></tr> <tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"></td></tr> <tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div>[[Category:Project_organisation]]</div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div>[[Category:Project_organisation]]</div></td></tr> <!-- diff generator: internal 2024-03-29 12:44:29 --> </table> Mon, 08 Aug 2011 13:14:38 GMT Richard Noragon https://lipidomicnet.org/index.php/Talk:P13_BABRAHAM Richard Noragon at 10:41, 17 June 2011 https://lipidomicnet.org/index.php?title=P13_BABRAHAM&diff=10758&oldid=prev <p></p> <table style="background-color: white; color:black;"> <col class='diff-marker' /> <col class='diff-content' /> <col class='diff-marker' /> <col class='diff-content' /> <tr valign='top'> <td colspan='2' style="background-color: white; color:black;">←Older revision</td> <td colspan='2' style="background-color: white; color:black;">Revision as of 10:41, 17 June 2011</td> </tr> <tr><td colspan="2" class="diff-lineno">Line 7:</td> <td colspan="2" class="diff-lineno">Line 7:</td></tr> <tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div>|myContribution=The Wakelam laboratory brings expertise in the study of signal transduction pathways to LipidomicNet. The lab has developed HPLC-MS methods for the analysis of lipids including the phosphoinositides. The lab has expertise in the generation of genetically modified mouse models and through&nbsp; association with Birmingham University access to human samples and</div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div>|myContribution=The Wakelam laboratory brings expertise in the study of signal transduction pathways to LipidomicNet. The lab has developed HPLC-MS methods for the analysis of lipids including the phosphoinositides. The lab has expertise in the generation of genetically modified mouse models and through&nbsp; association with Birmingham University access to human samples and</div></td></tr> <tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div>DNA array facilities.</div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div>DNA array facilities.</div></td></tr> <tr><td class='diff-marker'>-</td><td style="background: #ffa; color:black; font-size: smaller;"><div>|myTaskforces=</div></td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div>|myTaskforces=<ins class="diffchange diffchange-inline">[[Task_Force_I|Task Force I]], [[Task_Force_II|Task Force II]], [[Task_Force_VI|Task Force VI]], [[Task_Force_VII|Task Force VII]], and [[Task_Force_IX|Task Force IX]]</ins></div></td></tr> <tr><td class='diff-marker'>-</td><td style="background: #ffa; color:black; font-size: smaller;"><div>|myWorkpackages=</div></td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div>|myWorkpackages=<ins class="diffchange diffchange-inline">[[WP4|WP4]]</ins></div></td></tr> <tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div>}}&lt;br&gt; &lt;br&gt; &nbsp;</div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div>}}&lt;br&gt; &lt;br&gt; &nbsp;</div></td></tr> <tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"></td></tr> <tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div>[[Category:Project_organisation]]</div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div>[[Category:Project_organisation]]</div></td></tr> <!-- diff generator: internal 2024-03-29 12:44:29 --> </table> Fri, 17 Jun 2011 10:41:51 GMT Richard Noragon https://lipidomicnet.org/index.php/Talk:P13_BABRAHAM Richard Noragon at 11:22, 26 May 2011 https://lipidomicnet.org/index.php?title=P13_BABRAHAM&diff=10263&oldid=prev <p></p> <table style="background-color: white; color:black;"> <col class='diff-marker' /> <col class='diff-content' /> <col class='diff-marker' /> <col class='diff-content' /> <tr valign='top'> <td colspan='2' style="background-color: white; color:black;">←Older revision</td> <td colspan='2' style="background-color: white; color:black;">Revision as of 11:22, 26 May 2011</td> </tr> <tr><td colspan="2" class="diff-lineno">Line 9:</td> <td colspan="2" class="diff-lineno">Line 9:</td></tr> <tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div>|myTaskforces=</div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div>|myTaskforces=</div></td></tr> <tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div>|myWorkpackages=</div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div>|myWorkpackages=</div></td></tr> <tr><td class='diff-marker'>-</td><td style="background: #ffa; color:black; font-size: smaller;"><div>}}</div></td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div>}}<ins class="diffchange diffchange-inline">&lt;br&gt; &lt;br&gt; </ins></div></td></tr> <tr><td colspan="2">&nbsp;</td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div>&#160;</div></td></tr> <tr><td colspan="2">&nbsp;</td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div><ins class="diffchange diffchange-inline">[[Category:Project_organisation]]</ins></div></td></tr> <!-- diff generator: internal 2024-03-29 12:44:29 --> </table> Thu, 26 May 2011 11:22:29 GMT Richard Noragon https://lipidomicnet.org/index.php/Talk:P13_BABRAHAM Stefan Lehneis at 12:14, 3 June 2008 https://lipidomicnet.org/index.php?title=P13_BABRAHAM&diff=4119&oldid=prev <p></p> <p><b>New page</b></p><div>{{Infobox_Institution<br /> |myInstitutionname=The Babraham Institute, Cambridge - Michael Wakelam<br /> |myLogo=<br /> |myCountry=United Kingdoms<br /> |myBenefitnr=P13<br /> |myAbout=<br /> |myContribution=The Wakelam laboratory brings expertise in the study of signal transduction pathways to LipidomicNet. The lab has developed HPLC-MS methods for the analysis of lipids including the phosphoinositides. The lab has expertise in the generation of genetically modified mouse models and through association with Birmingham University access to human samples and<br /> DNA array facilities.<br /> |myTaskforces=<br /> |myWorkpackages=<br /> }}</div> Tue, 03 Jun 2008 12:14:42 GMT Stefan Lehneis https://lipidomicnet.org/index.php/Talk:P13_BABRAHAM